Shopping Cart 0
Cart Subtotal
USD 0

Promore Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company's pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the prevention of post-surgical adhesions and dermal scarring. Promore's PXL01 is also used for Phase III trials on patients undergoing flexor tendon repair surgery in the hand. The company's LL-37 is used to promote wound healing in chronic leg ulcers. It provides product development, regulatory affairs, design and execution of clinical trial, and clinical development services. Promore is headquartered in Stockholm, Sweden.

Promore Pharma AB-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Promore Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Promore Pharma AB, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Promore Pharma Enters into Agreement with PCG Clinical Services 10

Promore Pharma Enters into Co-Development Agreement with Cellastra 11

Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 12

Licensing Agreements 13

PharmaResearch Products Enters into Licensing Agreement with Promore Pharma 13

Promore Pharma Enters into Licensing Agreement with Transdermal Therapeutic Technologies 14

Acquisition 15

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 15

Promore Pharma AB-Key Competitors 18

Promore Pharma AB-Key Employees 19

Promore Pharma AB-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Financial Announcements 21

Aug 20, 2018: Promore Pharma: Interim report January-June 2018 21

Aug 20, 2018: Promore Pharma: Interim report January-June 2018 23

May 16, 2018: Promore Pharma Announce Interim report January-March 2018 26

Nov 21, 2017: Promore Pharma: Interim report January-September 2017 27

Aug 30, 2017: Promore Pharma: Interim report January-June 2017 29

May 19, 2017: Promore Pharma: Interim report January-March 2017 30

May 19, 2017: Interim report January-March 2017 32

Corporate Communications 33

Apr 25, 2017: Promore Pharma elects Marianne Dicander Alexandersson as New Board Member and outlines plans for IPO 33

Other Significant Developments 34

Feb 06, 2018: Promore Pharma: Year-end report 2017 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Promore Pharma AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Promore Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Promore Pharma AB, Deals By Therapy Area, 2012 to YTD 2018 8

Promore Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Promore Pharma Enters into Agreement with PCG Clinical Services 10

Promore Pharma Enters into Co-Development Agreement with Cellastra 11

Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 12

PharmaResearch Products Enters into Licensing Agreement with Promore Pharma 13

Promore Pharma Enters into Licensing Agreement with Transdermal Therapeutic Technologies 14

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 15

Promore Pharma AB, Key Competitors 18

Promore Pharma AB, Key Employees 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Promore Pharma AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.